Grand Pharmaceutical Group Ltd. (512)

512 · Health Care · China China

Grand Pharmaceutical Group Ltd. (512) is a company in the Health Care sector, based in China. The stock is held in 1 ETF we track – with its largest weight of 0.01 % in IS3N (msci-em-imi). Anyone holding one of these ETFs also owns a small indirect stake in Grand Pharmaceutical Group.

How many funds hold this stock?

Low ETF coverage: 1 of the 95 ETFs we cover holds Grand Pharmaceutical Group, spread across one index. That places it among the least widely held names in index funds — of the 4,334 stocks we cover, none sits in fewer ETFs.

The line counts the funds we cover, not the market. Dashed: how many funds published a holdings list on that date.

Data note 1

Held in1 ETF
Highest weight0.01 %
Indices1
SectorHealth Care
CountryChina

Data note 2

What ETF is Grand Pharmaceutical Group in?

What ETF is Grand Pharmaceutical Group in
ETFIndexWeightper €1,000 in the ETF
IS3Nmsci-em-imi0.01 %€0.10

Data note 3

The last column turns the weight into euros: this much of €1,000 invested in one of these funds is allocated to Grand Pharmaceutical Group as of the fund's latest holdings list.

Weight in IS3N since 2021

Dec 31, 2021Sep 18, 2026

In IS3N, a fund tracking the MSCI EM IMI, Grand Pharmaceutical Group had a weight of 0.01 % on Dec 31, 2021 and 0.01 % on Sep 18, 2026. Its share peaked at 0.01 % on Dec 31, 2021. The weight rises and falls with the stock's price relative to the other index members, and it also shifts when the index provider changes the composition.

Data note 4

How much Grand Pharmaceutical Group Ltd. overlaps with other holdings in a portfolio is shown by the What's Inside Your ETF Portfolio and the ETF overlap check.

Stocks with similar ETF exposure

Names that reach a portfolio through largely the same funds as Grand Pharmaceutical Group — the figure counts the ETFs holding both.

Data note 5

Latest Investment Analysis: Stocks